This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Find out more here.

eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
New eMC coming June 2013...

AbbVie Limited

Abbott House, Vanwall Business Park, Vanwall Road, Maidenhead, SL6 4XE
Telephone: +44 (0)1628 561 090
Fax: +44 (0)1628 644 185
WWW: http://www.abbvie.co.uk
Medical Information e-mail: ukmedinfo@abbvie.com
Out of Hours Telephone: +44 (0)1628 774 920

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Patient Information Leaflet last updated on the eMC: 01/10/2013
PIL Duodopa intestinal gel

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 01/10/2013 and displayed until Current
Reasons for adding or updating:
  • Change to section 2 - what you need to know - contraindications
Updated on 08/02/2013 and displayed until 01/10/2013
Reasons for adding or updating:
  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 6 - marketing authorisation holder
  • Change to section 6 - date of revision
Updated on 27/07/2012 and displayed until 08/02/2013
Reasons for adding or updating:
  • Change to side-effects
Updated on 04/10/2010 and displayed until 27/07/2012
Reasons for adding or updating:
  • Change due to harmonisation of PIL.
  • Change of licence holder
  • Change to warnings or special precautions for use
Updated on 12/11/2008 and displayed until 04/10/2010
Reasons for adding or updating:
  • Change of manufacturer
Updated on 18/03/2008 and displayed until 12/11/2008
Reasons for adding or updating:
  • Change to side-effects
  • Correction of spelling/typing errors
Updated on 10/08/2006 and displayed until 18/03/2008
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics